Both in a murine model of CCl4-induced liver fibrosis and in a line of human HSCs, the inhibition of SphK1/S1P axis has been recently shown to contribute to the antifibrogenic effects of the indole (González-Fernández et al., 2017). Here, SPHK1 is linked to Hepatic fibrosis.